Compare RBLX & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBLX | GSK |
|---|---|---|
| Founded | 2006 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.5B | 95.3B |
| IPO Year | 2021 | N/A |
| Metric | RBLX | GSK |
|---|---|---|
| Price | $95.54 | $48.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 1 |
| Target Price | ★ $144.00 | N/A |
| AVG Volume (30 Days) | ★ 7.1M | 4.4M |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 3.42% |
| EPS Growth | N/A | ★ 118.57 |
| EPS | N/A | ★ 1.79 |
| Revenue | $4,463,713,000.00 | ★ $43,237,357,842.00 |
| Revenue This Year | $87.95 | $6.08 |
| Revenue Next Year | $21.71 | $5.22 |
| P/E Ratio | ★ N/A | $27.19 |
| Revenue Growth | ★ 32.70 | 2.73 |
| 52 Week Low | $50.10 | $31.72 |
| 52 Week High | $150.59 | $49.31 |
| Indicator | RBLX | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 38.41 | 61.78 |
| Support Level | $91.06 | $47.13 |
| Resistance Level | $95.36 | $49.31 |
| Average True Range (ATR) | 4.03 | 0.61 |
| MACD | 0.88 | -0.01 |
| Stochastic Oscillator | 49.12 | 78.60 |
Roblox operates a free-to-play online video game platform with about 110 million daily active users. This platform has spawned a virtual universe and a Roblox economy based on the Robux currency. The platform houses millions of games from a wide range of creators—spanning from young gamers themselves to professional development studios. Roblox offers creators the tools, publishing abilities, and platform for their games, enabling anyone to create a game. Creators earn money when gamers make optional in-game purchases within their games and by offering space for real-world advertising, and Roblox earns revenue primarily by taking a cut of these earnings.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.